Related Experiment Video
Updated: Mar 21, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Left ventricular noncompaction cardiomyopathy in end-stage heart failure patients undergoing orthotopic heart
Giulia Ottaviani1, Ana Maria Segura2, Indranee N Rajapreyar3
1Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA; "Lino Rossi" Research Center for the study and prevention of unexpected perinatal death and sudden infant death syndrome (SIDS)-Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Insights
Left ventricular noncompaction (LVNC) is an uncommon cause of end-stage heart failure in heart transplant recipients, primarily seen in nonischemic cardiomyopathy. Further research is needed to clarify diagnostic criteria for LVNC.
Area of Science:
- Cardiology
- Pathology
- Genetics
Background:
- Left ventricular noncompaction (LVNC) is a cardiomyopathy resulting from abnormal embryonic development of heart trabeculae.
- Diagnosis is typically by echocardiography, but its prevalence and pathological features in heart transplant explants are understudied.
Purpose of the Study:
- To investigate the occurrence and clinicopathological characteristics of LVNC in explanted hearts from orthotopic heart transplant (OHT) recipients.
- To compare echocardiographic and pathological findings for LVNC diagnosis.
Main Methods:
- Reviewed clinical, echocardiographic, and pathological data from 105 end-stage heart failure patients undergoing OHT.
- Assessed explanted hearts for LVNC, grading myocardial fibrosis, hypertrophy, and myocytolysis.
- Calculated measurements of noncompacted and compacted left ventricular walls and their ratio.
Main Results:
- LVNC was identified in 7.8% of nonischemic cardiomyopathy patients (4/51), but none with ischemic cardiomyopathy.
- Echocardiograms showed severe left ventricular dilatation, prominent trabeculations, and low ejection fraction (<20%).
- Pathological analysis revealed significant noncompacted myocardium (22±5.8mm) with a high noncompacted/compacted ratio (1.7/1).
Conclusions:
- LVNC is an infrequent cause of nonischemic cardiomyopathy leading to OHT.
- Variability in noncompacted/compacted ratios and discordance between imaging and pathology highlight the need for refined diagnostic criteria.
- Larger studies correlating clinical, anatomical, and genetic factors are essential for understanding LVNC's role in advanced heart failure.
Background:
Previous studies reported that left ventricular noncompaction (LVNC) is a cardiomyopathy, familial or sporadic, arising from arrest of the normal process of trabecular remodeling during embryonic development. The diagnosis is usually made by echocardiography, but to date, there has been little research on the occurrence and clinicopathological features of LVNC in the explanted hearts of orthotopic heart transplant (OHT) recipients.
Design:
The clinical, echocardiographic, and pathologic findings were reviewed for evidence of LVNC, diagnosed by echocardiographic criteria, in 105 patients with end-stage heart failure (HF) undergoing OHT. Analyses of multiple sections of the explanted hearts were carried out. The hearts were evaluated for grades (0, negative; 1, mild/occasional foci; 2, moderate/multiple foci; 3, severe/extensive, diffuse) of fibrosis, reactive and replacement, hypertrophy, myocytolysis in left ventricle, right ventricle, interventricular septum, and atria. Absolute measurements of noncompacted and compacted portions of the left ventricle wall and noncompacted/compacted ratios were calculated.
Results:
Isolated LVNC was observed in 0 of 54 ischemic cardiomyopathy and in 4 of 51 (7.8%) nonischemic cardiomyopathy patients - 2 men and 2 women, with a mean age±SEM of 34.2±6.9years. The echocardiogram disclosed marked left ventricular dilatation, prominent trabeculations, and left ventricle ejection fraction <20%. Mural thrombi were seen in 3 of 4 (75%) patients. The heart weight mean±SEM was 468±55.3 g (range, 340-600g); noncompacted myocardium was 22±5.8mm, compacted myocardium was 13.2±3.5mm, and noncompacted/compacted ratio was 1.7/1±0.2. The total scores of hypetrophy, myocytolysis, and fibrosis were as follows: left ventricle, 7.7±0.2; right ventricle, 6.2±0.5; interventricular septum, 6.7±0.2; and atria, 7.5±0.3.
Conclusions:
LVNC is an unusual form of nonischemic cardiomyopathy in patients suffering from end-stage HF undergoing OHT. The variability in the noncompacted/compacted ratio and discordance between the echocardiographic and pathological findings points to the need for further clarification of diagnostic imaging and diagnostic criteria for LVNC. Further studies in larger series, correlating the anatomoclinical and genetic variables, also would improve our understanding of LVNC as a cause of advanced HF leading to OHT.
More Related Videos
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VII: Pre and Post Operative Nursing Management